A Study of Auxora in Patients With Critical COVID-19 Pneumonia

Stopped The trial was terminated early due to the limited number of new COVID-19 hospitalizations.

Conditions

• Pneumonia

Interventions

• DRUG: CM4620-IE (Injectable Emulsion)
• DRUG: Placebo

Sponsor

CalciMedica, Inc.

Collaborators

• [object Object]